1
Clinical Trials associated with Drep-HIV-PT1 / Active, not recruitingPhase 1IIT EHVA P01/ANRS VRI08: A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults
EHVA P01 is an international, phase I, prophylactic HIV vaccine trial to evaluate the safety and immunogenicity of HIV Clade C DREP alone and in Combination with a Clade C ENV protein in healthy HIV-uninfected adults.
100 Clinical Results associated with Drep-HIV-PT1
100 Translational Medicine associated with Drep-HIV-PT1
100 Patents (Medical) associated with Drep-HIV-PT1
100 Deals associated with Drep-HIV-PT1